Biodesix's Series F - III Round

Biodesix raised a round of funding on March 06, 2018.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Series F - III Round: